Biofrontera Inc.
Clinical trials sponsored by Biofrontera Inc., explained in plain language.
A biopharmaceutical company focused on dermatological treatments, including photodynamic therapy for skin conditions.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New light therapy could zap stubborn acne without pills
Disease control CompletedThis study tests a treatment called photodynamic therapy (PDT) for adults with moderate to severe acne. A gel called Ameluz® is applied to the face, then activated with a special red light. The goal is to see if this combination reduces acne lesions better than a placebo. About 1…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New light therapy could zap precancerous skin spots on Hard-to-Treat areas
Disease control CompletedThis study tests a gel (Ameluz®) plus red light therapy for actinic keratosis, rough precancerous patches on skin. It includes 172 adults with 4-15 spots on arms, legs, neck, or trunk. The goal is to see if the treatment clears these spots better than a placebo gel.
Phase: PHASE3 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC